Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes.

Cardiovascular therapeutics

Waluś-Miarka M, Kapusta M, Miarka P, Kawalec E, Idzior-Waluś B.
PMID: 35024053
Cardiovasc Ther. 2021 Dec 21;2021:7956161. doi: 10.1155/2021/7956161. eCollection 2021.

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in the regulation of LDL metabolism. There is evidence that circulating PCSK9 is a cardiovascular risk factor. In this study, we determined factors associated with circulating PCSK9 in a group of...

Cite
Waluś-Miarka M, Kapusta M, Miarka P, et al. Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes. Cardiovasc Ther. 2021;2021:7956161doi: 10.1155/2021/7956161.
Waluś-Miarka, M., Kapusta, M., Miarka, P., Kawalec, E., & Idzior-Waluś, B. (2021). Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes. Cardiovascular therapeutics, 20217956161. https://doi.org/10.1155/2021/7956161
Waluś-Miarka, Małgorzata, et al. "Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes." Cardiovascular therapeutics vol. 2021 (2021): 7956161. doi: https://doi.org/10.1155/2021/7956161
Waluś-Miarka M, Kapusta M, Miarka P, Kawalec E, Idzior-Waluś B. Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes. Cardiovasc Ther. 2021 Dec 21;2021:7956161. doi: 10.1155/2021/7956161. eCollection 2021. PMID: 35024053; PMCID: PMC8714359.
Copy Download .nbib Format: NLM
APO B/APO AI Ratio with Coronary Artery Disease with Normal Lipid Profile in the Indian Population.

The Journal of the Association of Physicians of India

Modi R, Kothiwale VA, Patted S, Halkati PC.
PMID: 31556268
J Assoc Physicians India. 2017 Oct;65(12):22-27.

BACKGROUND: Abnormal lipids are an important risk factor for development of Coronary Artery Disease, significant patients have normal lipid profile and yet develop CAD. Apolipoproteins B, Apolipoproteins A and their ratio have been shown to be better predictor of...

Cite
Modi R, Kothiwale VA, Patted S, et al. APO B/APO AI Ratio with Coronary Artery Disease with Normal Lipid Profile in the Indian Population. J Assoc Physicians India. 2017;65(12):22-27
Modi, R., Kothiwale, V. A., Patted, S., & Halkati, P. C. (2017). APO B/APO AI Ratio with Coronary Artery Disease with Normal Lipid Profile in the Indian Population. The Journal of the Association of Physicians of India, 65(12), 22-27.
Modi, Ranjan, et al. "APO B/APO AI Ratio with Coronary Artery Disease with Normal Lipid Profile in the Indian Population." The Journal of the Association of Physicians of India vol. 65,12 (2017): 22-27.
Modi R, Kothiwale VA, Patted S, Halkati PC. APO B/APO AI Ratio with Coronary Artery Disease with Normal Lipid Profile in the Indian Population. J Assoc Physicians India. 2017 Oct;65(12):22-27. PMID: 31556268.
Copy Download .nbib Format: NLM
Lipoprotein-thyroid hormone interactions.

Trends in endocrinology and metabolism: TEM

Benvenga S, Robbins J.
PMID: 18407156
Trends Endocrinol Metab. 1993 Aug;4(6):194-8. doi: 10.1016/1043-2760(93)90116-v.

A small but significant portion of the thyroid hormones that circulate in human plasma is associated with lipoproteins. Although the major lipoprotein carrier is HDL, the role of these interactions on T(4) entry into cells was tested first with...

Cite
Benvenga S, Robbins J. Lipoprotein-thyroid hormone interactions. Trends Endocrinol Metab. 1993;4(6):194-8doi: 10.1016/1043-2760(93)90116-v.
Benvenga, S., & Robbins, J. (1993). Lipoprotein-thyroid hormone interactions. Trends in endocrinology and metabolism: TEM, 4(6), 194-8. https://doi.org/10.1016/1043-2760(93)90116-v
Benvenga, S, and Robbins, J. "Lipoprotein-thyroid hormone interactions." Trends in endocrinology and metabolism: TEM vol. 4,6 (1993): 194-8. doi: https://doi.org/10.1016/1043-2760(93)90116-v
Benvenga S, Robbins J. Lipoprotein-thyroid hormone interactions. Trends Endocrinol Metab. 1993 Aug;4(6):194-8. doi: 10.1016/1043-2760(93)90116-v. PMID: 18407156.
Copy Download .nbib Format: NLM
Serum Apolipoprotein B and A1 Concentrations Predict Late-Onset Posttransplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients.

Canadian journal of kidney health and disease

Malyala R, Rapi L, Nash MM, Prasad GVR.
PMID: 31205732
Can J Kidney Health Dis. 2019 May 25;6:2054358119850536. doi: 10.1177/2054358119850536. eCollection 2019.

BACKGROUND: Glucose metabolism links closely to cholesterol metabolism. Posttransplant diabetes mellitus (PTDM) adversely affects posttransplant outcomes, but its risk factors in relation to cholesterol metabolism have not been fully delineated. The apolipoprotein B/A1 (Apo B/A1) ratio, which is associated...

Cite
Malyala R, Rapi L, Nash MM, et al. Serum Apolipoprotein B and A1 Concentrations Predict Late-Onset Posttransplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients. Can J Kidney Health Dis. 2019;6:2054358119850536doi: 10.1177/2054358119850536.
Malyala, R., Rapi, L., Nash, M. M., & Prasad, G. V. R. (2019). Serum Apolipoprotein B and A1 Concentrations Predict Late-Onset Posttransplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients. Canadian journal of kidney health and disease, 62054358119850536. https://doi.org/10.1177/2054358119850536
Malyala, Rohit, et al. "Serum Apolipoprotein B and A1 Concentrations Predict Late-Onset Posttransplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients." Canadian journal of kidney health and disease vol. 6 (2019): 2054358119850536. doi: https://doi.org/10.1177/2054358119850536
Malyala R, Rapi L, Nash MM, Prasad GVR. Serum Apolipoprotein B and A1 Concentrations Predict Late-Onset Posttransplant Diabetes Mellitus in Prevalent Adult Kidney Transplant Recipients. Can J Kidney Health Dis. 2019 May 25;6:2054358119850536. doi: 10.1177/2054358119850536. eCollection 2019. PMID: 31205732; PMCID: PMC6535897.
Copy Download .nbib Format: NLM
Effect of obstructive jaundice on the regulation of hepatic cholesterol metabolism in the rat. Disappearance of abcg5 and abcg8 mRNA after bile duct ligation.

Hepatology research : the official journal of the Japan Society of Hepatology

Kamisako T, Ogawa H.
PMID: 12644045
Hepatol Res. 2003 Feb;25(2):99-104. doi: 10.1016/s1386-6346(02)00248-6.

The purpose of this study is to evaluate the effect of bile duct ligation (BDL) on changes of lipoprotein metabolism and hepatic gene expressions that are important for cholesterol metabolism. In male rats serum, very low-density lipoprotein cholesterol, low-density...

Cite
Kamisako T, Ogawa H. Effect of obstructive jaundice on the regulation of hepatic cholesterol metabolism in the rat. Disappearance of abcg5 and abcg8 mRNA after bile duct ligation. Hepatol Res. 2003;25(2):99-104doi: 10.1016/s1386-6346(02)00248-6.
Kamisako, T., & Ogawa, H. (2003). Effect of obstructive jaundice on the regulation of hepatic cholesterol metabolism in the rat. Disappearance of abcg5 and abcg8 mRNA after bile duct ligation. Hepatology research : the official journal of the Japan Society of Hepatology, 25(2), 99-104. https://doi.org/10.1016/s1386-6346(02)00248-6
Kamisako, Toshinori, and Ogawa, Hiroshi. "Effect of obstructive jaundice on the regulation of hepatic cholesterol metabolism in the rat. Disappearance of abcg5 and abcg8 mRNA after bile duct ligation." Hepatology research : the official journal of the Japan Society of Hepatology vol. 25,2 (2003): 99-104. doi: https://doi.org/10.1016/s1386-6346(02)00248-6
Kamisako T, Ogawa H. Effect of obstructive jaundice on the regulation of hepatic cholesterol metabolism in the rat. Disappearance of abcg5 and abcg8 mRNA after bile duct ligation. Hepatol Res. 2003 Feb;25(2):99-104. doi: 10.1016/s1386-6346(02)00248-6. PMID: 12644045.
Copy Download .nbib Format: NLM
Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia: A Pilot, Randomised, Double-Blind, Dose-Titrating Study.

Clinical drug investigation

Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, Athyrou VV, Kontopoulos AG.
PMID: 18370543
Clin Drug Investig. 1998;16(3):219-27. doi: 10.2165/00044011-199816030-00006.

OBJECTIVE: To investigate the effect of atorvastatin vs simvastatin on lipid profile and plasma fibrinogen in patients with hypercholesterolaemia.PATIENTS: 30 outpatients (25 men), with a median age of 51 years were studied. Eight patients had established coronary artery disease...

Cite
Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, et al. Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia: A Pilot, Randomised, Double-Blind, Dose-Titrating Study. Clin Drug Investig. 1998;16(3):219-27doi: 10.2165/00044011-199816030-00006.
Athyros, V. G., Papageorgiou, A. A., Hatzikonstandinou, H. A., Athyrou, V. V., & Kontopoulos, A. G. (1998). Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia: A Pilot, Randomised, Double-Blind, Dose-Titrating Study. Clinical drug investigation, 16(3), 219-27. https://doi.org/10.2165/00044011-199816030-00006
Athyros, V G, et al. "Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia: A Pilot, Randomised, Double-Blind, Dose-Titrating Study." Clinical drug investigation vol. 16,3 (1998): 219-27. doi: https://doi.org/10.2165/00044011-199816030-00006
Athyros VG, Papageorgiou AA, Hatzikonstandinou HA, Athyrou VV, Kontopoulos AG. Effect of Atorvastatin versus Simvastatin on Lipid Profile and Plasma Fibrinogen in Patients with Hypercholesterolaemia: A Pilot, Randomised, Double-Blind, Dose-Titrating Study. Clin Drug Investig. 1998;16(3):219-27. doi: 10.2165/00044011-199816030-00006. PMID: 18370543.
Copy Download .nbib Format: NLM
Clinical impact of non-high density lipoprotein-cholesterol and apolipoprotein B on clinical outcomes in metabolic syndrome patients with acute myocardial infarction undergoing percutaneous coronary intervention.

Korean circulation journal

Ahmed K, Jeong MH, Chakraborty R, Hong YJ, Oh MS, Cho KH, Kim MC, Hachinohe D, Hwang SH, Lee MG, Sim DS, Park KH, Kim JH, Ahn Y, Kang JC.
PMID: 22701134
Korean Circ J. 2012 May;42(5):319-28. doi: 10.4070/kcj.2012.42.5.319. Epub 2012 May 24.

BACKGROUND AND OBJECTIVES: Non-high density lipoprotein-cholesterol (non-HDL-C) and apolipoprotein B (ApoB) are markers of atherosclerotic risk and predictors of cardiovascular events. The aim of this study was to evaluate clinical impact of non-HDL-C and ApoB on clinical outcomes in...

Cite
Ahmed K, Jeong MH, Chakraborty R, et al. Clinical impact of non-high density lipoprotein-cholesterol and apolipoprotein B on clinical outcomes in metabolic syndrome patients with acute myocardial infarction undergoing percutaneous coronary intervention. Korean Circ J. 2012;42(5):319-28doi: 10.4070/kcj.2012.42.5.319.
Ahmed, K., Jeong, M. H., Chakraborty, R., Hong, Y. J., Oh, M. S., Cho, K. H., Kim, M. C., Hachinohe, D., Hwang, S. H., Lee, M. G., Sim, D. S., Park, K. H., Kim, J. H., Ahn, Y., & Kang, J. C. (2012). Clinical impact of non-high density lipoprotein-cholesterol and apolipoprotein B on clinical outcomes in metabolic syndrome patients with acute myocardial infarction undergoing percutaneous coronary intervention. Korean circulation journal, 42(5), 319-28. https://doi.org/10.4070/kcj.2012.42.5.319
Ahmed, Khurshid, et al. "Clinical impact of non-high density lipoprotein-cholesterol and apolipoprotein B on clinical outcomes in metabolic syndrome patients with acute myocardial infarction undergoing percutaneous coronary intervention." Korean circulation journal vol. 42,5 (2012): 319-28. doi: https://doi.org/10.4070/kcj.2012.42.5.319
Ahmed K, Jeong MH, Chakraborty R, Hong YJ, Oh MS, Cho KH, Kim MC, Hachinohe D, Hwang SH, Lee MG, Sim DS, Park KH, Kim JH, Ahn Y, Kang JC. Clinical impact of non-high density lipoprotein-cholesterol and apolipoprotein B on clinical outcomes in metabolic syndrome patients with acute myocardial infarction undergoing percutaneous coronary intervention. Korean Circ J. 2012 May;42(5):319-28. doi: 10.4070/kcj.2012.42.5.319. Epub 2012 May 24. PMID: 22701134; PMCID: PMC3369963.
Copy Download .nbib Format: NLM
Assessment of apolipoprotein B/apolipoprotein A-I ratio in non-ST segment elevation acute coronary syndrome patients.

The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology

Galal H, Samir A, Shehata M.
PMID: 32449038
Egypt Heart J. 2020 May 24;72(1):27. doi: 10.1186/s43044-020-00057-1.

BACKGROUND: The apolipoprotein B/apolipoprotein A-I ratio was shown to be strongly related to the risk of myocardial infarction in several large-scale studies. The current study aimed at exploring the diagnostic and short-term prognostic values of apolipoprotein B/apolipoprotein A-I ratio...

Cite
Galal H, Samir A, Shehata M. Assessment of apolipoprotein B/apolipoprotein A-I ratio in non-ST segment elevation acute coronary syndrome patients. Egypt Heart J. 2020;72(1):27doi: 10.1186/s43044-020-00057-1.
Galal, H., Samir, A., & Shehata, M. (2020). Assessment of apolipoprotein B/apolipoprotein A-I ratio in non-ST segment elevation acute coronary syndrome patients. The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology, 72(1), 27. https://doi.org/10.1186/s43044-020-00057-1
Galal, Haitham, et al. "Assessment of apolipoprotein B/apolipoprotein A-I ratio in non-ST segment elevation acute coronary syndrome patients." The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology vol. 72,1 (2020): 27. doi: https://doi.org/10.1186/s43044-020-00057-1
Galal H, Samir A, Shehata M. Assessment of apolipoprotein B/apolipoprotein A-I ratio in non-ST segment elevation acute coronary syndrome patients. Egypt Heart J. 2020 May 24;72(1):27. doi: 10.1186/s43044-020-00057-1. PMID: 32449038; PMCID: PMC7246270.
Copy Download .nbib Format: NLM
An investigation of human apolipoproteins B and E polymorphisms in two African populations from Ethiopia and Benin.

American journal of human biology : the official journal of the Human Biology Council

Corbo RM, Scacchi R, Rickards O, Martinez-Labarga C, De Stefano GF.
PMID: 11533951
Am J Hum Biol. 1999;11(3):297-304. doi: 10.1002/(SICI)1520-6300(1999)11:3<297::AID-AJHB2>3.0.CO;2-B.

Three polymorphisms (XbaI, EcoRI, and Ins/Del) of the apolipoprotein B (APOB) gene and the polymorphism of apolipoprotein E (APOE) were investigated in two population samples of Amhara and Oromo origin from Ethiopia, and in two population samples of Bariba...

Cite
Corbo RM, Scacchi R, Rickards O, et al. An investigation of human apolipoproteins B and E polymorphisms in two African populations from Ethiopia and Benin. Am J Hum Biol. 1999;11(3):297-304doi: 10.1002/(SICI)1520-6300(1999)11:3<297::AID-AJHB2>3.0.CO;2-B.
Corbo, R. M., Scacchi, R., Rickards, O., Martinez-Labarga, C., & De Stefano, G. F. (1999). An investigation of human apolipoproteins B and E polymorphisms in two African populations from Ethiopia and Benin. American journal of human biology : the official journal of the Human Biology Council, 11(3), 297-304. https://doi.org/10.1002/(SICI)1520-6300(1999)11:3<297::AID-AJHB2>3.0.CO;2-B
Corbo, R.M., et al. "An investigation of human apolipoproteins B and E polymorphisms in two African populations from Ethiopia and Benin." American journal of human biology : the official journal of the Human Biology Council vol. 11,3 (1999): 297-304. doi: https://doi.org/10.1002/(SICI)1520-6300(1999)11:3<297::AID-AJHB2>3.0.CO;2-B
Corbo RM, Scacchi R, Rickards O, Martinez-Labarga C, De Stefano GF. An investigation of human apolipoproteins B and E polymorphisms in two African populations from Ethiopia and Benin. Am J Hum Biol. 1999;11(3):297-304. doi: 10.1002/(SICI)1520-6300(1999)11:3<297::AID-AJHB2>3.0.CO;2-B. PMID: 11533951.
Copy Download .nbib Format: NLM
The Correlation between Serum ApoA1 and B and Coronary Artery Disease as Well as Its Severity.

International cardiovascular research journal

Mashayekhi NR, Sadrnia S, Chehrei A, Javaheri J.
PMID: 24757643
Int Cardiovasc Res J. 2014 Jan;8(1):1-5. Epub 2014 Jan 01.

BACKGROUND: Some patients with Coronary Artery Disease (CAD) have no well-known risk factors of this disease, but are diagnosed with cardiovascular events. The present study aimed to assess the association between Apo A1 and ApoB and the severity of...

Cite
Mashayekhi NR, Sadrnia S, Chehrei A, et al. The Correlation between Serum ApoA1 and B and Coronary Artery Disease as Well as Its Severity. Int Cardiovasc Res J. 2014;8(1):1-5
Mashayekhi, N. R., Sadrnia, S., Chehrei, A., & Javaheri, J. (2014). The Correlation between Serum ApoA1 and B and Coronary Artery Disease as Well as Its Severity. International cardiovascular research journal, 8(1), 1-5.
Mashayekhi, Navid Reza, et al. "The Correlation between Serum ApoA1 and B and Coronary Artery Disease as Well as Its Severity." International cardiovascular research journal vol. 8,1 (2014): 1-5.
Mashayekhi NR, Sadrnia S, Chehrei A, Javaheri J. The Correlation between Serum ApoA1 and B and Coronary Artery Disease as Well as Its Severity. Int Cardiovasc Res J. 2014 Jan;8(1):1-5. Epub 2014 Jan 01. PMID: 24757643; PMCID: PMC3987460.
Copy Download .nbib Format: NLM
Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes.

Cardiovascular therapeutics

Waluś-Miarka M, Kapusta M, Miarka P, Kawalec E, Idzior-Waluś B.
PMID: 35024053
Cardiovasc Ther. 2021 Dec 21;2021:7956161. doi: 10.1155/2021/7956161. eCollection 2021.

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in the regulation of LDL metabolism. There is evidence that circulating PCSK9 is a cardiovascular risk factor. In this study, we determined factors associated with circulating PCSK9 in a group of...

Cite
Waluś-Miarka M, Kapusta M, Miarka P, et al. Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes. Cardiovasc Ther. 2021;2021:7956161doi: 10.1155/2021/7956161.
Waluś-Miarka, M., Kapusta, M., Miarka, P., Kawalec, E., & Idzior-Waluś, B. (2021). Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes. Cardiovascular therapeutics, 20217956161. https://doi.org/10.1155/2021/7956161
Waluś-Miarka, Małgorzata, et al. "Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes." Cardiovascular therapeutics vol. 2021 (2021): 7956161. doi: https://doi.org/10.1155/2021/7956161
Waluś-Miarka M, Kapusta M, Miarka P, Kawalec E, Idzior-Waluś B. Serum PCSK9 Correlates with PTX3 and Apolipoproteins B, A1, and C3 Concentrations in Patients with Type 2 Diabetes. Cardiovasc Ther. 2021 Dec 21;2021:7956161. doi: 10.1155/2021/7956161. eCollection 2021. PMID: 35024053; PMCID: PMC8714359.
Copy Download .nbib Format: NLM
ApoC-III and visceral adipose tissue contribute to paradoxically normal triglyceride levels in insulin-resistant African-American women.

Nutrition & metabolism

Sumner AE, Furtado JD, Courville AB, Ricks M, Younger-Coleman N, Tulloch-Reid MK, Sacks FM.
PMID: 24365086
Nutr Metab (Lond). 2013 Dec 23;10(1):73. doi: 10.1186/1743-7075-10-73.

BACKGROUND: African-Americans are more insulin-resistant than whites but have lower triglyceride (TG) concentrations. The metabolic basis for this is unknown. Our goal was to determine in a cross-sectional study the effect of insulin resistance, visceral adipose tissue (VAT) and...

Cite
Sumner AE, Furtado JD, Courville AB, et al. ApoC-III and visceral adipose tissue contribute to paradoxically normal triglyceride levels in insulin-resistant African-American women. Nutr Metab (Lond). 2013;10(1):73doi: 10.1186/1743-7075-10-73.
Sumner, A. E., Furtado, J. D., Courville, A. B., Ricks, M., Younger-Coleman, N., Tulloch-Reid, M. K., & Sacks, F. M. (2013). ApoC-III and visceral adipose tissue contribute to paradoxically normal triglyceride levels in insulin-resistant African-American women. Nutrition & metabolism, 10(1), 73. https://doi.org/10.1186/1743-7075-10-73
Sumner, Anne E, et al. "ApoC-III and visceral adipose tissue contribute to paradoxically normal triglyceride levels in insulin-resistant African-American women." Nutrition & metabolism vol. 10,1 (2013): 73. doi: https://doi.org/10.1186/1743-7075-10-73
Sumner AE, Furtado JD, Courville AB, Ricks M, Younger-Coleman N, Tulloch-Reid MK, Sacks FM. ApoC-III and visceral adipose tissue contribute to paradoxically normal triglyceride levels in insulin-resistant African-American women. Nutr Metab (Lond). 2013 Dec 23;10(1):73. doi: 10.1186/1743-7075-10-73. PMID: 24365086; PMCID: PMC3878037.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries